Company / PP&E per Share
NeoGenomics Laboratories, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.66
FY2025
5-year range
$0.66 / $0.91
FY2021-FY2025
Trend
-10.9%
vs FY2024
Sector context
#100 of 128
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s pp&e per share of $0.66 is lower than 78% of companies in the Health Care sector (FY2025). PP&E per Share has fluctuated over the past 10 years, ranging from $0.45 in FY2016 to $0.91 in FY2021.
Based on SEC 10-K filings.
0.66 in FY2025 with a 5-year CAGR of -2.9%.
Declined from $0.73 to $0.66 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -7.1%
- 5-Year CAGR
- -2.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 128This company $0.66 Sector average $11.86
▼
-94.4% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 10.9% year-over-year.
- Ranks #100 out of 128 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2021.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.66 | -10.9% |
| FY2024 | $0.74 | +1.3% |
| FY2023 | $0.73 | -11.2% |
| FY2022 | $0.83 | -9.6% |
| FY2021 | $0.91 | +18.8% |
| FY2020 | $0.77 | +24.0% |
| FY2019 | $0.62 | -6.8% |
| FY2018 | $0.66 | +43.1% |
| FY2017 | $0.46 | +3.5% |
| FY2016 | $0.45 | -21.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026